2018 (4th) International Symposium on Next-Generation CAR & TCR-T Cells
Chimeric antigen receptors are engineered receptors that combine a new specificity with an immune cell to target cancer cells. Typically, these receptors graft the specificity of a monoclonal antibody onto a T cell. CAR-T cells are a new type of treatment that uses living cells that have been transformed.
2018 China Summit of Probiota
Probiota is a group of microorganisms that are claimed to provide health benefits when consumed. The introduction of the concept (but not the term) is generally attributed to Nobel laureate Élie Metchnikoff, who postulated that yogurt-consuming Bulgarian peasants lived longer lives because of this custom.
2018 ( 10th ) International Conference on Stem Cells
After nearly 20 years' development, there have been almost 100 companies focusing on technology R&D on stem cells, establishment of stem cell banks and application of stem cells. This conference will facilitate communication and cooperation among researchers at home and abroad.
2018 International Forum on Innovative Drug R&D
With a population of 1.3 billion people and a rapidly expanding economy, China has recently risen to become the third largest pharmaceutical market globally. Several multinational pharmaceutical companies have now located R&D centres in China, and Chinese pharmaceutical companies are increasingly focusing on innovative drug R&D.
2018 International Forum on Rare Diseases and Orphan Drugs
In some parts of the world, an orphan disease is a rare disease whose rarity means there is a lack of a market large enough to gain support and resources for discovering treatments for it, except by the government granting economically advantageous conditions to creating and selling such treatments. Orphan drugs are ones so created or sold.
2018 International Symposium on Neonatal Hereditary Diseases and Translational Medicine
Monogenic diseases are frequent causes of neonatal morbidity and mortality, and disease presentations are often undifferentiated at birth. More than 3500 monogenic diseases have been characterized, but clinical testing is available for only some of them and many feature clinical and genetic heterogeneity.
2018 International Forum on Biotechnological Drugs
Biotechnological drugs are a wide group of therapeutic agents obtained by means of genetic engineering methodologies. This forum will provide you with the latest technologies, the whole industry and the market of novel antibodies, antibody drugs, new vaccine development, new vaccine industry, protein modification in China.
2018 International Forum on Novel Antibodies
An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein produced mainly by plasma cells that is used by the immune systemto neutralize pathogens such as pathogenic bacteria and viruses. The antibody recognizes a unique molecule of the pathogen, called an antigen, via the Fab's variable region.
2018 International Forum on Novel Vaccines
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future.
2018 (3rd) International Symposium on Protein Modification and Diseases
Protein Modification refers to the covalent and generally enzymatic modification of proteins following protein biosynthesis, which is of great importance in cell signaling. Modification of proteins can be experimentally detected by a variety of techniques, including mass spectrometry, Eastern blotting, and Western blotting.